Skip to Content

DARZALEX

In the US, DARZALEX (daratumumab systemic) is a member of the drug class CD38 monoclonal antibodies and is used to treat Multiple Myeloma.

US matches:

Ingredient matches for DARZALEX

Daratumumab

Daratumumab is reported as an ingredient of DARZALEX in the following countries:

  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide